rethinkPeptides Search
Menu
Study breakdown

Thymosin Alpha-1 Directly Kills Leukemia Cells by Triggering Apoptosis

In VitroPreliminary evidence
The takeaway

Thymosin alpha-1 suppressed proliferation and induced apoptosis in human leukemia cell lines, demonstrating direct anti-leukemic activity beyond its immune-enhancing effects — a dual anti-cancer mechanism.

Key finding

Thymosin alpha-1 directly suppressed proliferation and induced apoptosis in human leukemia cell lines (HL-60, K562, Raji) through caspase activation,

What the researchers found

Thymosin alpha-1 directly suppressed proliferation and induced apoptosis in human leukemia cell lines (HL-60, K562, Raji) through caspase activation, demonstrating direct cytotoxic anti-leukemic activity alongside its known immune enhancement.

Why it matters

Relevant for thymosin-alpha-1, cancer, immune-function.

How the study worked

in-vitro study on thymosin-alpha-1, cancer.

What this study cannot tell us

See abstract.

How to read the evidence

preliminary evidence.

When this study was published

Published in 2006.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.
  • Clinical translation to evaluate.

Common questions

What was studied?
Thymosin Alpha-1 Directly Kills Leukemia Cells by Triggering Apoptosis
What was found?
Thymosin alpha-1 suppressed proliferation and induced apoptosis in human leukemia cell lines, demonstrating direct anti-leukemic activity beyond its immune-enhancing effects — a dual anti-cancer mechanism.

Read the original research

Thymosin alpha1 suppresses proliferation and induces apoptosis in human leukemia cell lines.

Peptides, 27(9), 2165-73

Citation

Fan, Ying-zhe; Chang, Hui; Yu, Ye; Liu, Jing; Wang, Rui. (2006). Thymosin alpha1 suppresses proliferation and induces apoptosis in human leukemia cell lines.. Peptides, 27(9), 2165-73.